Strep Throat Treatment Market Trends

  • Report ID: 5964
  • Published Date: Sep 16, 2025
  • Report Format: PDF, PPT

Strep Throat Treatment Market Growth Drivers and Challenges:

Growth Drivers

  • Increasing Global Awareness for AIDS, Flue and Ebolaviruses - Global HIV infection rates are predicted to reach 1.3 million in 2022, a 38% decrease from 2010 and a 59% decrease from the peak in 1995. In contrast to the number of persons who receive an HIV diagnosis within a year, new HIV infections, also known as "HIV incidence," refer to the estimated number of people who freshly acquired HIV during a certain period, such as a year. The resurgent Ebola virus disease (EVD) and the human immunodeficiency virus (HIV) are closely related and continue to pose a concern to public health worldwide. Their rapid spread and similar origins are accompanied by overlapping qualities that have an influence, such as linked symptoms and other interactions. Rapid response policies and evidence-based implementation results are necessary due to the global threat posed by these viruses and their disputes.

  • Rising Concern about AIDS Globally -In 2022, there were about 39 million HIV-positive individuals in the world. Of them, 1.5 million were children under the age of fifteen, and 37.5 million were adults. Furthermore, 53% of the population was female. In 2022, about 86% of HIV-positive individuals worldwide were aware of their status. About 5.5 million persons, or 14% of the population, were HIV-negative and in need of testing services. The first step in HIV prevention, treatment, care, and support services is HIV testing. 95% of people worldwide should be aware of their HIV status by 2025. The increasing use of HIV drugs\medicines is the result that people are becoming aware of aids.  

  • Increasing Government Initiatives to Reduce Streptococcus Infection Globally - Lowering the risk of a severe infection with iGAS can be achieved by reducing the transmission of GAS. Life-saving treatment for patients with iGAS illness can be started as soon as possible after the condition is identified. Therefore, public health authorities should think about initiatives to educate physicians and the general public, as well as promote early detection and treatment of GAS infections following national recommendations.

Challenges

  • Adverse Impacts Related to Strep Throat Medications - Usually, doctors recommend antibiotics to treat the strep throat bacteria, hasten your recovery, and lower your risk of developing serious consequences. Amoxicillin and penicillin are the two antibiotics that are most frequently prescribed. For people with strep throat, these medications are the primary choice because they are generally protected, moderately priced, and efficient at curing streptococcal infections in the throat. Penicillin allergies may be treated with azithromycin, cefixime, clarithromycin, or clindamycin. Unsettling stomach, yeast infections, and oral thrush (yeast overgrowth) are common antibiotic side effects.

  • Antibiotic side effects include vomiting, diarrhea, oral thrush (yeast overgrowth in the mouth), nausea, and yeast infections are common. The list of adverse effects is not exhaustive. People should talk to a healthcare provider, including your doctor, about potential side effects and drug interactions. Consuming a lot of hot liquids, like broth, soups, and hot tea. This can help you stay hydrated and relieve some of the discomfort from your sore throat.

  • Lack of Knowledge in People
  • Inclination Towards Home Remedies Over Medication

Base Year

2025

Forecast Period

2026-2035

CAGR

4.3%

Base Year Market Size (2025)

USD 2.28 billion

Forecast Year Market Size (2035)

USD 3.47 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of strep throat treatment is estimated at USD 2.37 billion.

The global strep throat treatment market size crossed USD 2.28 billion in 2025 and is likely to expand at a CAGR of more than 4.3%, surpassing USD 3.47 billion revenue by 2035.

North America strep throat treatment market will dominate around 38% share by 2035, fueled by rising advancements in technology in the region.

Key players in the market include Pfizer Inc., Astrazeneca, Novartis AG, Bayer AG, GSK plc., Melinta Therapeutics, Amgen Inc., Teva Pharmaceutical Industries Ltd., Merck & co, Inc., Johnson & Johnson Service, Inc., Takeda Pharmaceutical Company Limited, Sanofi, Mitsubishi Chemical Group Corp., Daiichi Sankyo Co Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos